Prof. Dr.

Thomas Carell

B1
C3
Principal Investigator

Prof. Dr.

Thomas Carell

Chair of Organic Chemistry, Institute of Chemical Epigenetics and Department of Chemistry, Faculty of Chemistry and Pharmacy

Ludwig-Maximilians-Universität München

Research background

DNA and RNA are chemically dynamic molecules whose function is shaped by a wide spectrum of natural and synthetic modifications. Regulatory and epigenetic base modifications influence gene expression, while detrimental DNA lesions threaten genome stability and must be efficiently repaired. How non-canonical nucleobases are formed, detected, and processed in cells, how lesions are recognized by repair enzymes and polymerases, and how chemical modification can be harnessed to expand the functional scope of nucleic acids remain central questions in chemical biology.

The research of Thomas Carell focuses on the chemical biology of nucleic acids, with particular emphasis on DNA and RNA modifications. His work combines synthetic chemistry with structural and analytical approaches to investigate lesion recognition and repair, including crystallographic studies of lesion-containing DNA bound to repair enzymes and polymerases, which revealed mechanisms such as dinucleotide flip-out and electron transfer in UV-lesion repair. He developed Cu(I)-catalyzed click chemistry for high-density DNA modification and new sequencing and mass spectrometry methods to quantify non-canonical bases, including isotope-labeled RNA modifications. By advancing chemical tools, structural insight, and analytical technologies, this research deepens understanding of genome maintenance and RNA regulation and enables applications in diagnostics and DNA-based materials.

Research fields
Publications

Pseudouridine RNA avoids immune detection through impaired endolysosomal processing and TLR engagement.

Bérouti, M.; Wagner, M.; Greulich, W.; Piseddu, I.; Gärtig, J.; Hansbauer, L.; Müller-Hermes, C.; Heiss, M.; Pichler, A.; Tölke, AJ.; Witte, G.; Hopfner, KP.; Anz, D.; Sattler, M.; Carell, T.; Hornung, V.

Cell. · 2025

Show abstract

Recognition of exogenous RNA by Toll-like receptors (TLRs) is central to pathogen defense. Using two distinct binding pockets, TLR7 and TLR8 recognize RNA degradation products generated by endolysosomal nucleases. RNA modifications present in endogenous RNA prevent TLR activation; notably, pseudouridine-containing RNA lacks immunostimulatory activity. Indeed, this property has been critical to the successful implementation of mRNA technology for medical purposes. However, the molecular mechanism for this immune evasion has remained elusive. Here, we report that RNase T2 and PLD exonucleases do not adequately process pseudouridine-containing RNA to generate TLR-agonistic ligands. As a second safety mechanism, TLR8 neglects pseudouridine as a ligand for its first binding pocket and TLR7 neglects pseudouridine-containing RNA as a ligand for its second pocket. Interestingly, the medically used N1-methylpseudouridine also evades RNase T2, PLD3, and PLD4 processing but is able to directly activate TLR8. Taken together, our findings provide a molecular basis for self-avoidance by RNA-sensing TLRs.

A prebiotically plausible scenario of an RNA-peptide world.

Müller, F.; Escobar, L.; Xu, F.; Węgrzyn, E.; Nainytė, M.; Amatov, T.; Chan, CY.; Pichler, A.; Carell, T.

Nature. · 2022

Show abstract

The RNA world concept is one of the most fundamental pillars of the origin of life theory. It predicts that life evolved from increasingly complex self-replicating RNA molecules. The question of how this RNA world then advanced to the next stage, in which proteins became the catalysts of life and RNA reduced its function predominantly to information storage, is one of the most mysterious chicken-and-egg conundrums in evolution. Here we show that non-canonical RNA bases, which are found today in transfer and ribosomal RNAs, and which are considered to be relics of the RNA world, are able to establish peptide synthesis directly on RNA. The discovered chemistry creates complex peptide-decorated RNA chimeric molecules, which suggests the early existence of an RNA-peptide world from which ribosomal peptide synthesis may have emerged. The ability to grow peptides on RNA with the help of non-canonical vestige nucleosides offers the possibility of an early co-evolution of covalently connected RNAs and peptides, which then could have dissociated at a higher level of sophistication to create the dualistic nucleic acid-protein world that is the hallmark of all life on Earth.

Unified prebiotically plausible synthesis of pyrimidine and purine RNA ribonucleotides.

Becker, S.; Feldmann, J.; Wiedemann, S.; Okamura, H.; Schneider, C.; Iwan, K.; Crisp, A.; Rossa, M.; Amatov, T.; Carell, T.

Science. · 2019

Show abstract

Theories about the origin of life require chemical pathways that allow formation of life's key building blocks under prebiotically plausible conditions. Complex molecules like RNA must have originated from small molecules whose reactivity was guided by physico-chemical processes. RNA is constructed from purine and pyrimidine nucleosides, both of which are required for accurate information transfer, and thus Darwinian evolution. Separate pathways to purines and pyrimidines have been reported, but their concurrent syntheses remain a challenge. We report the synthesis of the pyrimidine nucleosides from small molecules and ribose, driven solely by wet-dry cycles. In the presence of phosphate-containing minerals, 5'-mono- and diphosphates also form selectively in one-pot reactions. The pathway is compatible with purine synthesis, allowing the concurrent formation of all Watson-Crick bases.

The discovery of 5-formylcytosine in embryonic stem cell DNA.

Pfaffeneder, T.; Hackner, B.; Truss, M.; Münzel, M.; Müller, M.; Deiml, CA.; Hagemeier, C.; Carell, T.

Angew Chem Int Ed Engl. · 2011

Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase eta.

Alt, A.; Lammens, K.; Chiocchini, C.; Lammens, A.; Pieck, JC.; Kuch, D.; Hopfner, KP.; Carell, T.

Science. · 2007

Show abstract

DNA polymerase eta (Pol eta) is a eukaryotic lesion bypass polymerase that helps organisms to survive exposure to ultraviolet (UV) radiation, and tumor cells to gain resistance against cisplatin-based chemotherapy. It allows cells to replicate across cross-link lesions such as 1,2-d(GpG) cisplatin adducts (Pt-GG) and UV-induced cis-syn thymine dimers. We present structural and biochemical analysis of how Pol eta copies Pt-GG-containing DNA. The damaged DNA is bound in an open DNA binding rim. Nucleotidyl transfer requires the DNA to rotate into an active conformation, driven by hydrogen bonding of the templating base to the dNTP. For the 3'dG of the Pt-GG, this step is accomplished by a Watson-Crick base pair to dCTP and is biochemically efficient and accurate. In contrast, bypass of the 5'dG of the Pt-GG is less efficient and promiscuous for dCTP and dATP as a result of the presence of the rigid Pt cross-link. Our analysis reveals the set of structural features that enable Pol eta to replicate across strongly distorting DNA lesions.